Notably, cellular communication network factor 1 (CCN1) signaling, through α6β1 integrin, promotes an endocrine‐resistant phenotype, potentially through the direct binding of CCN1 to ERα, thus regulating transcriptional events in ERα+ breast cancer cells (Fig. 4) [56]. The gene discussed is ESR1; the disease is breast carcinoma.